2238
E. Tamanini et al. / Tetrahedron: Asymmetry 17 (2006) 2235–2239
4.2.1. anti-4d (major diastereoisomer). TLC (n-hexane/
EtOAc 8:2), Rf = 0.54; IR (thin film) 1732, 1496,
4.5. Cyclopent-3-enecarboxylic acid tert-butyldiphenylsilyl
ester 6e
1454 cmꢀ1 1H NMR (CDCl3, 270 MHz): d = 7.22 (m,
;
5H), 5.02 (s, 2H), 3.34 (s, 2H), 2.60 (app. quin,
J = 8.1 Hz, 1H), 2.22 (dd, J = 13.8 and 8.1 Hz, 2H), 1.77
(dd, J = 13.8 and 9.9 Hz, 2H); 13C NMR (CDCl3,
67.5 MHz): d = 174.5, 136.2, 128.6, 128.2, 128.0, 66.2,
56.0, 37.5, 31.2. HRMS (ESI) calcd for [M+Na]+,
(C13H14O3Na)+ 241.0835, found 241.0832.
TBDPSCl (1.1 mmol, 306 mg) was added to a solution of
3-cyclopenten-1-carboxylic acid (1 mmol, 211 mg), DIPEA
(2 mmol, 258 mg) and DMAP (10 mol %) in DCM
(10 mL), and the mixture stirred overnight at rt. The reac-
tion mixture was washed with brine and the aqueous layer
extracted with DCM (3 · 20 mL). The organic phases were
collected, dried over MgSO4 and concentrated in vacuo.
The crude material was purified by flash-chromatography
on silica gel (n-hexane 100% to n-hexane/EtOAc, 7:3) to
give 6e as a clear liquid (248 mg, 71%). TLC (n-hexane/
EtOAc 8:2), Rf = 0.74; IR (thin film): 1724, 1473,
4.2.2. syn-4d (minor diastereoisomer). TLC (n-hexane/
EtOAc 8:2), Rf = 0.38; IR (thin film) 1732, 1496,
1454 cmꢀ1 1H NMR (CDCl3, 270 MHz): d = 7.33 (m,
;
5H), 5.11 (s, 2H), 3.46 (s, 2H), 2.78–2.69 (m, 3H), 1.85
(dd, J = 14.6 and 9.1 Hz, 2H).
1427 cmꢀ1 1H NMR (CDCl3, 270 MHz): d = 7.66 (m,
;
4H), 7.37 (m, 6H), 5.68 (s, 2H), 3.26 (m, 1H), 2.72 (m,
4H), 1.09 (s, 9H); 13C NMR (CDCl3, 67.5 MHz):
d = 175.1, 135.5, 132.2, 130.3, 129.3, 127.9, 43.6, 36.5,
27.2, 19.4. HRMS (ESI) calcd for [M+Na]+, (C22H26O2Si-
Na)+ 373.1594, found 373.1593.
4.3. (1R,3S,4S)-3-Azido-4-trimethylsilanyloxy-cyclo-
pentane-1-carboxylic acid benzyl ester 2d
To a solution of (1R,2R)-(ꢀ)-[1,2-cyclohexanediamino-
N,N0-bis(3,5-di-tert-butylsalicylidene)]chromium(III) chlo-
ride (0.02 mol, 13 mg) in dry Et2O was added anti-4d
(1 mmol, 218 mg) under N2. After 15 min, TMSN3
(1.1 mmol, 127 mg) was added and the brown solution stir-
red at room temperature for 30 h. The solvent was removed
in vacuo and the residue filtered through a plug of silica gel
with n-hexane/EtOAc (8:2) to provide 2d as a pale yellow
oil (95% yield, 85% ee). The ee was determined by chiral
HPLC (n-hexane/i-PrOH 99.7:0.3 CHIRACEL OD
0.45 · 25 cm, 1 mL/min). Rt = 13.867 min (minor enantio-
mer) and 15.527 min (major enantiomer). The other enan-
tiomer was prepared following the same procedure using
(1S,2S) catalyst (Rt = 13.867 min). Assignment of absolute
stereochemistry is based on the assignments previously
reported.7 TLC (n-hexane/EtOAc 8:2), Rf = 0.79; IR (thin
film) 2106, 1732, 1265 cmꢀ1; 1H NMR (CDCl3, 270 MHz):
d = 7.34 (m, 5H), 5.13 (s, 2H), 4.07 (dd, J = 11.1 and
5.4 Hz, 1H), 3.68 (dd, J = 11.8 and 6.9 Hz, 1H), 3.06
(app. quin, J = 7.4 Hz, 1H), 2.36–2.15 (m, 2H), 1.93–1.82
(m, 2H), 0.13 (s, 9H); 13C NMR (CDCl3, 67.5 MHz):
d = 174.9, 136.0, 128.7, 128.3, 128.2, 76.9, 68.0, 66.7,
39.1, 35.8, 31.8, 0.04. HRMS (ESI) calcd for [M+H]+,
(C16H24N3O3Si)+ 334.1581, found 334.1581.
4.6. anti-3,4-Epoxycyclopentanecarboxylic acid tert-butyl-
diphenylsilyl ester anti-4e
To a cooled solution (0 ꢁC) of 6e (1 mmol, 366 mg) in
DCM (10 mL) was added m-CPBA (1.3 equiv, 224 mg) in
three portions. The solution was allowed to warm to room
temperature and stirred at the same temperature for 4 h.
The white precipitate formed was filtered and the solid res-
idue rinsed with DCM. The organic layer was then washed
with a saturated NaHCO3 solution and 10% Na2SO4 solu-
tion. The organic phase was dried over MgSO4 and concen-
trated. The two diastereoisomers were separated by flash
column chromatography on silica gel (n-hexane/EtOAc
9:1 to 7:3) to give anti- and syn-epoxides as white solids
in 81% overall yield and diastereomeric ratio (anti:syn)
85:15.
4.6.1. anti-4e (major diastereoisomer). TLC (n-hexane/
EtOAc 8:2), Rf = 0.53; Mp: 82–83 ꢁC; IR (thin film)
1716, 1427, 1330 cmꢀ1 1H NMR (CDCl3, 270 MHz):
;
d = 7.64 (m, 4H), 7.39 (m, 6H), 3.52 (s, 2H), 2.83 (m,
1H), 2.42 (dd, J = 14.1 and 7.9 Hz, 2H), 1.92 (dd,
J = 14.1 and 9.9 Hz, 2H), 1.08 (s, 9H); 13C NMR (CDCl3,
67.5 MHz): d = 173.9, 135.4, 131.8, 130.3, 127.9, 56.4, 39.3,
31.3, 27.0, 19.3. HRMS (ESI) calcd for [M+Na]+,
(C22H26O3SiNa)+ 389.1543, found 389.1546.
4.4. (1R,3S,4S)-3-Azido-4-hydroxy-cyclopentane-1-carb-
oxylic acid 2
To a solution of 2d (1 mmol, 333 mg) in THF (10 mL) was
added 1 M NaOH (4 mL). The mixture was stirred at rt for
4 h. THF was evaporated and the aqueous phase extracted
with DCM (three times). The aqueous phase was acidified
with 10% HCl to pH 4 and concentrated. The residue was
taken up with DCM and the precipitate filtered. The solid
was rinsed with DCM, and the organic phase dried over
MgSO4 and concentrated in vacuo to give 2 as a pale
yellow oil (82% yield). IR (thin film) 3700–2400 (broad),
4.6.2. syn-4e (minor diastereoisomer). TLC (n-hexane/
EtOAc 8:2), Rf = 0.40; Mp: 93–95 ꢁC; IR (thin film)
1716, 1427, 1330 cmꢀ1 1H NMR (CDCl3, 270 MHz):
;
d = 7.69 (m, 4H), 7.37 (m, 6H), 3.50 (s, 2H), 2.80 (m,
3H), 1.88 (dd, J = 14.6 and 8.9 Hz, 2H), 1.11 (s, 9H).
4.7. (1R,3S,4S)-3-Azido-4-trimethylsilanyloxy-cyclo-
pentane-1-carboxylic acid tert-butyldiphenylsilyl ester 2e
3348, 2110, 1708, 1419 cmꢀ1
;
1H NMR (CDCl3,
270 MHz): d = 6.50 (br s, 1H), 4.17 (m, 1H), 3.76 (m,
1H), 3.18–2.98 (m, 1H), 2.49–2.10 (m, 2H), 2.10–1.84 (m,
2H); 13C NMR (CDCl3, 67.5 MHz): d = 180.6, 76.6, 67.7,
39.1, 35.2, 32.0. HRMS (ESI) calcd for [M+Na]+,
(C6H9N3O3Na)+ 194.0536, found 194.0535.
To a solution of (1R,2R)-(ꢀ)-[1,2-cyclohexanediamino-
N,N0-bis(3,5-di-tert-butylsalicylidene)]chromium(III) chlo-
ride (0.05 mol, 33 mg) in dry Et2O (5 mL) was added
anti-4e (1 mmol, 366 mg) under N2. After 15 min, TMSN3
(3 mmol, 346 mg) was added and the brown solution stir-